Daniel Seekins - Concepedia

Author

Daniel Seekins

Bristol-Myers Squibb (United States)

Also Known As

Bollinger, Mary, D Seekins, D.W. Seekins, Daniel Seekins, Daniel W Seekins, Daniel W. Seekins, Wood, Jennifer J

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Health Economics and Outcomes Research (United Kingdom)University of Southern California Precision for Medicine (United States)

About

Daniel Seekins is an author at Bristol-Myers Squibb (United States) specializing in public health, medicine, and health economics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	124
2	Public Health	5	5	124
3	Nursing	1	1	17
4	Allied Health Professions	1	1	17
5	Epidemiology	1	1	21

Daniel Seekins

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1 Jeffrey L. Lennox, Raphael J. Landovitz, Heather J. Ribaudo, Annals of Internal Medicine	2014	255
Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients Edwin DeJesus, Benjamin Young, Javier O Morales-Ramirez, JAIDS Journal of Acquired Immune Deficiency Syndromes	2009	133
Prevalence and Clinical Significance of HIV Drug Resistance Mutations by Ultra-Deep Sequencing in Antiretroviral-Naïve Subjects in the CASTLE Study Max Lataillade, Jennifer Chiarella, Rong Yang, PLoS ONE	2010	130
The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection Adrian S. Dobs, Joseph Cofrancesco, William E Nolten, The American Journal of Medicine	1999	68
Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: beyond mitochondrial DNA depletion. Grace A. McComsey, Renkui Bai, Jen‐Fue Maa, PubMed	2005	51
Randomization to Once-Daily Stavudine Extended Release/Lamivudine/Efavirenz Versus a More Frequent Regimen Improves Adherence While Maintaining Viral Suppression Brian A Boyle, Dushyantha Jayaweera, Mallory D. Witt, HIV Clinical Trials	2008	45
Nearly 60,000 Uninsured And Low-Income People With HIV/AIDS Live In States That Are Not Expanding Medicaid Julia Thornton Snider, Timothy Juday, John A. Romley, Health Affairs Health Care DisparityHealthcare UtilizationHealth ReformHealthcare ProvisionExpanding Medicaid	2014	40
Virologic Failures on Initial Boosted-PI Regimen Infrequently Possess Low-Level Variants with Major PI Resistance Mutations by Ultra-Deep Sequencing Max Lataillade, Jennifer Chiarella, Rong Yang, PLoS ONE	2012	38
Therapy with Efavirenz plus Indinavir in Patients with Extensive Prior Nucleoside Reverse‐Transcriptase Inhibitor Experience: A Randomized, Double‐Blind, Placebo‐Controlled Trial David W. Haas, W. Jeffrey Fessel, Robert Delapenha, The Journal of Infectious Diseases	2001	37
Early HIV Treatment Led To Life Expectancy Gains Valued At $80 Billion For People Infected In 1996–2009 John A. Romley, Timothy Juday, Matthew D. Solomon, Health Affairs Mortality StudiesCombination Antiretroviral TherapyPreventive MedicineHiv/aids CounsellingHuman Retrovirus	2014	35

Page 1